BBA
Baker Bros. Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.05M | Buy |
+280,000
| New | +$8.05M | 0.08% | 57 |
|
|
2024
Q4 | – | Sell |
-103,927
| Closed | -$5.31M | – | 99 |
|
|
2024
Q3 | $5.31M | Hold |
103,927
| – | – | 0.06% | 66 |
|
|
2024
Q2 | $4.65M | Buy |
+103,927
| New | +$4.65M | 0.06% | 68 |
|
|
2022
Q4 | – | Sell |
-735,716
| Closed | -$14.4M | – | 117 |
|
|
2022
Q3 | $14.4M | Sell |
735,716
-91,764
| -11% | -$1.8M | 0.09% | 55 |
|
|
2022
Q2 | $15.4M | Hold |
827,480
| – | – | 0.09% | 56 |
|
|
2022
Q1 | $18.2M | Hold |
827,480
| – | – | 0.1% | 56 |
|
|
2021
Q4 | $23.5M | Sell |
827,480
-93,176
| -10% | -$2.65M | 0.11% | 53 |
|
|
2021
Q3 | $19.4M | Hold |
920,656
| – | – | 0.09% | 63 |
|
|
2021
Q2 | $17.4M | Buy |
920,656
+304,136
| +49% | +$5.73M | 0.08% | 65 |
|
|
2021
Q1 | $9.42M | Hold |
616,520
| – | – | 0.04% | 78 |
|
|
2020
Q4 | $8.7M | Buy |
616,520
+314,200
| +104% | +$4.43M | 0.03% | 78 |
|
|
2020
Q3 | $4.74M | Sell |
302,320
-15,537
| -5% | -$243K | 0.02% | 82 |
|
|
2020
Q2 | $5.57M | Buy |
317,857
+142,857
| +82% | +$2.5M | 0.02% | 78 |
|
|
2020
Q1 | $2.57M | Hold |
175,000
| – | – | 0.02% | 83 |
|
|
2019
Q4 | $4.39M | Hold |
175,000
| – | – | 0.02% | 74 |
|
|
2019
Q3 | $2.63M | Buy |
175,000
+42,015
| +32% | +$632K | 0.02% | 83 |
|
|
2019
Q2 | $3.33M | Buy |
132,985
+1,735
| +1% | +$43.4K | 0.02% | 71 |
|
|
2019
Q1 | $2.99M | Hold |
131,250
| – | – | 0.02% | 71 |
|
|
2018
Q4 | $3.94M | Hold |
131,250
| – | – | 0.03% | 59 |
|
|
2018
Q3 | $3.76M | Buy |
+131,250
| New | +$3.76M | 0.02% | 77 |
|